Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Reporting of Medicine Shortages

Drugline Volume 351

The Therapeutic Goods Amendment (2018 Measures No. 1) Bill 2018 has passed the Senate and will come into effect on 1st January 2019. The main focus of this bill concerns the communication of medicine…

Read more

Appropriate use of slow-release opioids

Drugline Volume 350

The Australian and New Zealand College of Anaesthetists (ANZCA) has released a position statement recommending that slow-release opioids should not be used for the management of acute pain. For the purposes of this discussion,…

Read more

Indications Extended for Ixekizumab

Drugline Volume 349

The indications for ixekizumab have been extended to include the treatment of active psoriatic arthritis in addition to moderate to severe plaque psoriasis. Ixekizumab is a humanised monoclonal antibody with neutralising activity against the…

Read more

Ryzodeg®: A New Mixed Insulin

Drugline Volume 348

From the 1st August 2018, a new insulin preparation is available on the Pharmaceutical Benefits Scheme (PBS). Ryzodeg® 70/30 is a soluble insulin analogue containing 70% ultra-long-acting basal insulin and 30% rapid-acting prandial insulin….

Read more

Ribociclib for Breast Cancer

Drugline Volume 347

Ribociclib is a novel kinase inhibitor recently added to the Pharmaceutical Benefits Scheme (PBS). It is indicated for the treatment of locally advanced or metastatic breast cancer that is hormone receptor positive and human epidermal growth…

Read more

Glucagon-like Peptide-1 Analogues

Drugline Volume 346

Dulaglutide (Trulicity®) is a new glucagon-like peptide-1 (GLP-1) analogue available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of type 2 diabetes. GLP-1 is an intestinally-derived incretin hormone that is key in the…

Read more
Load More

September 2018

August 2018

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012